A review summarizing studies in animals as well as a few in humans describes that hyperglycemia-induced aberrant levels of INS or INS growth factors (IGF) may lead to neuropathic complications, intensifying pain through mechanisms such as central sensitization. This evidence concerns the gene INS and Hyperglycemia.